Project Grant R01AG088347
Award Date
8/15/24
Completion Date
6/30/29
Dollars Obligated
$1.6M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $1,198,127 Project Grant (CFDA 93.866 - Aging Research) to the Regents of the University of Michigan to develop new measures to characterize the financial hardship experienced by families of individuals with Alzheimer's disease and related dementias (ADRD). The project will involve conducting semi-structured interviews with ADRD caregivers, performing a scoping review, and obtaining input from experts to develop a new measurement system that can...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $2,336,705 to the University of Delaware to develop and validate novel measurement tools to quantify financial hardship and health disparities experienced by individuals living with Alzheimer's disease and related dementias (ADRD), as well as their families and caregivers. The key objectives are to: 1) identify experiences of financial hardship through qualitative interviews and focus...
This Project Grant awarded by the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), will fund the development and validation of an Inclusive Screener for AD/ADRD Financial Expenses (I-SAFE). The project aims to create a measure of financial hardship that is inclusive of persons living with Alzheimer's disease or related dementias (PLWD) and their care contributors, including those from sexual and gender minority populations. The $1,188,879 award,...
The National Institute on Aging (NIA) awarded a $198,995 Project Grant (CFDA 93.866, Aging Research) to the University of Utah to develop and validate a comprehensive measure of the financial impacts experienced by family caregivers of people living with Alzheimer's disease and related dementias (AD/ADRD). The study aims to: (1) engage diverse family caregivers and their social networks to identify areas of financial impact, (2) develop and pilot a quantitative measure of the financial impact of...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
The National Institute on Aging awarded a $539,635 Project Grant under the Aging Research program (CFDA 93.866) to The RAND Corporation to develop a family-based macro-simulation model examining the supply and demand of care for Alzheimer's disease and related dementias (ADRD). The project aims to simulate individual- and family-level economic and well-being outcomes based on the factors influencing ADRD caregiving, including care needs, caregiver availability, and the cost of formal care. The...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to evaluate the effects of poverty alleviation policies on the risk and disparities of Alzheimer's disease and related dementias (AD/ADRD). The $131,813 award to Trustees of Boston University, awarded on May 1, 2025, will support a research program with two key objectives: In the K99 phase, the researcher will integrate Health and Retirement Study (HRS) and Medicare data to quantify state-level...
This Project Grant award, titled "Care for Persons with Dementia in Medicare Advantage and Traditional Medicare: Family Spillovers and Disparities", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) for $2,462,393 with a project period from August 15, 2024 to April 30, 2029. The grant aims to study healthcare utilization and intergenerational transfers among Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD), comparing experiences...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...